{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:38:48Z","timestamp":1790156328901,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["SC1CA193758"],"award-info":[{"award-number":["SC1CA193758"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA118638"],"award-info":[{"award-number":["U54CA118638"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH1810429"],"award-info":[{"award-number":["W81XWH1810429"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13048-019-0517-1","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T14:44:51Z","timestamp":1557499491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Hypoxia-inducible factor-1\u03b1 induces CX3CR1 expression and promotes the epithelial to mesenchymal transition (EMT) in ovarian cancer cells"],"prefix":"10.1186","volume":"12","author":[{"given":"Santosh Kumar","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,10]]},"reference":[{"issue":"1","key":"517_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","volume":"14","author":"BM Reid","year":"2017","unstructured":"Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14(1):9\u201332.","journal-title":"Cancer Biol Med"},{"issue":"2","key":"517_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bpobgyn.2005.10.007","volume":"20","author":"R Sankaranarayanan","year":"2006","unstructured":"Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006;20(2):207\u201325.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"517_CR3","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3332\/ecancer.2016.626","volume":"10","author":"R Lokadasan","year":"2016","unstructured":"Lokadasan R, James FV, Narayanan G, Prabhakaran PK. Targeted agents in epithelial ovarian cancer: review on emerging therapies and future developments. Ecancermedicalscience. 2016;10:626.","journal-title":"Ecancermedicalscience"},{"issue":"1","key":"517_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1158\/1541-7786.MCR-11-0256","volume":"10","author":"M Kim","year":"2012","unstructured":"Kim M, Rooper L, Xie J, Kajdacsy-Balla AA, Barbolina MV. Fractalkine receptor CX(3)CR1 is expressed in epithelial ovarian carcinoma cells and required for motility and adhesion to peritoneal mesothelial cells. Mol Cancer Res. 2012;10(1):11\u201324.","journal-title":"Mol Cancer Res"},{"issue":"5","key":"517_CR5","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.3892\/ijo.2012.1610","volume":"41","author":"LJ Xiao","year":"2012","unstructured":"Xiao LJ, Chen YY, Lin P, Zou HF, Lin F, Zhao LN, Li D, Guo L, Tang JB, Zheng XL, et al. Hypoxia increases CX3CR1 expression via HIF-1 and NFkappaB in androgen-independent prostate cancer cells. Int J Oncol. 2012;41(5):1827\u201336.","journal-title":"Int J Oncol"},{"key":"517_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1186\/s12885-015-1539-8","volume":"15","author":"LM McEvoy","year":"2015","unstructured":"McEvoy LM, O'Toole SA, Spillane CD, Martin CM, Gallagher MF, Stordal B, Blackshields G, Sheils O, O'Leary JJ. Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer. BMC Cancer. 2015;15:547.","journal-title":"BMC Cancer"},{"issue":"8","key":"517_CR7","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/ijc.27448","volume":"131","author":"A Horiuchi","year":"2012","unstructured":"Horiuchi A, Hayashi T, Kikuchi N, Hayashi A, Fuseya C, Shiozawa T, Konishi I. Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1alpha to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene. Int J Cancer. 2012;131(8):1755\u201367.","journal-title":"Int J Cancer"},{"key":"517_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/HP.S93413","volume":"3","author":"B Muz","year":"2015","unstructured":"Muz B, de la Puente P, Azab F, Azab AK. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl). 2015;3:83\u201392.","journal-title":"Hypoxia (Auckl)"},{"issue":"7","key":"517_CR9","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/ijc.25176","volume":"127","author":"EK Rofstad","year":"2010","unstructured":"Rofstad EK, Gaustad JV, Egeland TA, Mathiesen B, Galappathi K. Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination. Int J Cancer. 2010;127(7):1535\u201346.","journal-title":"Int J Cancer"},{"issue":"20","key":"517_CR10","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1158\/0008-5472.CAN-13-1087","volume":"73","author":"FJ Sulzmaier","year":"2013","unstructured":"Sulzmaier FJ, Ramos JW. RSK isoforms in cancer cell invasion and metastasis. Cancer Res. 2013;73(20):6099\u2013105.","journal-title":"Cancer Res"},{"issue":"2","key":"517_CR11","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3892\/or.2015.4470","volume":"35","author":"J Tang","year":"2016","unstructured":"Tang J, Xiao L, Cui R, Li D, Zheng X, Zhu L, Sun H, Pan Y, Du Y, Yu X. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE\/TGF-alpha\/EGFR pathway in hypoxic androgen-independent prostate cancer cells. Oncol Rep. 2016;35(2):1153\u201362.","journal-title":"Oncol Rep"},{"issue":"2","key":"517_CR12","first-page":"151","volume":"27","author":"RJ Kurman","year":"2008","unstructured":"Kurman RJ, Shih Ie M. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol. 2008;27(2):151\u201360.","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"517_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3390\/ijms15010361","volume":"15","author":"GG Muralidhar","year":"2013","unstructured":"Muralidhar GG, Barbolina MV. Chemokine receptors in epithelial ovarian cancer. Int J Mol Sci. 2013;15(1):361\u201376.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"517_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3390\/biom5010223","volume":"5","author":"B Singha","year":"2015","unstructured":"Singha B, Gatla HR, Vancurova I. Transcriptional regulation of chemokine expression in ovarian cancer. Biomolecules. 2015;5(1):223\u201343.","journal-title":"Biomolecules"},{"issue":"24","key":"517_CR15","doi-asserted-by":"publisher","first-page":"10367","DOI":"10.1158\/0008-5472.CAN-08-2780","volume":"68","author":"J Wang","year":"2008","unstructured":"Wang J, Lu Y, Wang J, Koch AE, Zhang J, Taichman RS. CXCR6 induces prostate cancer progression by the AKT\/mammalian target of rapamycin signaling pathway. Cancer Res. 2008;68(24):10367\u201376.","journal-title":"Cancer Res"},{"issue":"8","key":"517_CR16","doi-asserted-by":"publisher","first-page":"e43399","DOI":"10.1371\/journal.pone.0043399","volume":"7","author":"T Zhao","year":"2012","unstructured":"Zhao T, Gao S, Wang X, Liu J, Duan Y, Yuan Z, Sheng J, Li S, Wang F, Yu M, et al. Hypoxia-inducible factor-1alpha regulates chemotactic migration of pancreatic ductal adenocarcinoma cells through directly transactivating the CX3CR1 gene. PLoS One. 2012;7(8):e43399.","journal-title":"PLoS One"},{"issue":"9","key":"517_CR17","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1084\/jem.20030267","volume":"198","author":"T Schioppa","year":"2003","unstructured":"Schioppa T, Uranchimeg B, Saccani A, Biswas SK, Doni A, Rapisarda A, Bernasconi S, Saccani S, Nebuloni M, Vago L, et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med. 2003;198(9):1391\u2013402.","journal-title":"J Exp Med"},{"key":"517_CR18","unstructured":"Aldo P, Elisabetta C. Role of HIF-1 in cancer progression: novel insights. A review. Curr Mol Med. 2018."},{"issue":"4","key":"517_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/0284186X.2017.1301680","volume":"56","author":"S Soni","year":"2017","unstructured":"Soni S, Padwad YS. HIF-1 in cancer therapy: two decade long story of a transcription factor. Acta Oncol. 2017;56(4):503\u201315.","journal-title":"Acta Oncol"},{"issue":"2","key":"517_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1158\/1541-7786.MCR-14-0150","volume":"13","author":"B Muz","year":"2015","unstructured":"Muz B, de la Puente P, Azab F, Ghobrial IM, Azab AK. Hypoxia promotes dissemination and colonization in new bone marrow niches in Waldenstrom macroglobulinemia. Mol Cancer Res. 2015;13(2):263\u201372.","journal-title":"Mol Cancer Res"},{"issue":"33","key":"517_CR21","doi-asserted-by":"crossref","first-page":"54136","DOI":"10.18632\/oncotarget.11250","volume":"8","author":"JF Liu","year":"2017","unstructured":"Liu JF, Tsao YT, Hou CH. Fractalkine\/CX3CL1 induced intercellular adhesion molecule-1-dependent tumor metastasis through the CX3CR1\/PI3K\/Akt\/NF-kappaB pathway in human osteosarcoma. Oncotarget. 2017;8(33):54136\u201348.","journal-title":"Oncotarget"},{"issue":"6617","key":"517_CR22","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/385640a0","volume":"385","author":"JF Bazan","year":"1997","unstructured":"Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ. A new class of membrane-bound chemokine with a CX3C motif. Nature. 1997;385(6617):640\u20134.","journal-title":"Nature"},{"issue":"6","key":"517_CR23","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.4049\/jimmunol.164.6.3368","volume":"164","author":"A Muehlhoefer","year":"2000","unstructured":"Muehlhoefer A, Saubermann LJ, Gu X, Luedtke-Heckenkamp K, Xavier R, Blumberg RS, Podolsky DK, MacDermott RP, Reinecker HC. Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J Immunol. 2000;164(6):3368\u201376.","journal-title":"J Immunol"},{"issue":"8","key":"517_CR24","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1002\/(SICI)1521-4141(199908)29:08<2551::AID-IMMU2551>3.0.CO;2-T","volume":"29","author":"EJ Papadopoulos","year":"1999","unstructured":"Papadopoulos EJ, Sassetti C, Saeki H, Yamada N, Kawamura T, Fitzhugh DJ, Saraf MA, Schall T, Blauvelt A, Rosen SD, et al. Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation. Eur J Immunol. 1999;29(8):2551\u20139.","journal-title":"Eur J Immunol"},{"issue":"4","key":"517_CR25","first-page":"1544","volume":"53","author":"P Liu","year":"2018","unstructured":"Liu P, Liang Y, Jiang L, Wang H, Wang S, Dong J. CX3CL1\/fractalkine enhances prostate cancer spinal metastasis by activating the Src\/FAK pathway. Int J Oncol. 2018;53(4):1544\u201356.","journal-title":"Int J Oncol"},{"issue":"14","key":"517_CR26","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1158\/0008-5472.CAN-12-3828","volume":"73","author":"M Tardaguila","year":"2013","unstructured":"Tardaguila M, Mira E, Garcia-Cabezas MA, Feijoo AM, Quintela-Fandino M, Azcoitia I, Lira SA, Manes S. CX3CL1 promotes breast cancer via transactivation of the EGF pathway. Cancer Res. 2013;73(14):4461\u201373.","journal-title":"Cancer Res"},{"key":"517_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2018.04.017","volume":"427","author":"SK Singh","year":"2018","unstructured":"Singh SK, Lillard JW Jr, Singh R. Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer. Cancer Lett. 2018;427:49\u201362.","journal-title":"Cancer Lett"},{"issue":"1","key":"517_CR28","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/s41598-018-19643-0","volume":"8","author":"SK Singh","year":"2018","unstructured":"Singh SK, Mishra MK, Eltoum IA, Bae S, Lillard JW Jr, Singh R. CCR5\/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells. Sci Rep. 2018;8(1):1323.","journal-title":"Sci Rep"},{"key":"517_CR29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2741\/e798","volume":"9","author":"S Banerjee","year":"2017","unstructured":"Banerjee S, Singh SK, Chowdhury I, Lillard JW Jr, Singh R. Combinatorial effect of curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancer. Front Biosci (Elite Ed). 2017;9:235\u201345.","journal-title":"Front Biosci (Elite Ed)"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-019-0517-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-019-0517-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-019-0517-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T17:20:07Z","timestamp":1663435207000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-019-0517-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,10]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["517"],"URL":"https:\/\/doi.org\/10.1186\/s13048-019-0517-1","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,10]]},"assertion":[{"value":"7 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"42"}}